Literature DB >> 28444319

Gender differences in the correlation between prognosis and postoperative weight loss in patients with non-small cell lung cancer.

Hideki Kawai1, Yoshitaro Saito1, Yohei Suzuki1.   

Abstract

OBJECTIVES: The aim of this study was to investigate gender differences in the relationship between preoperative body mass index (BMI), postoperative body weight change and prognosis in patients with non-small cell lung cancer (NSCLC).
METHODS: Two hundred and sixty-three patients with NSCLC were enrolled in this study. Preoperative BMI was categorized based on WHO definition as follows: underweight (BMI <18.5): 21 patients (8.0%), normal (18.5 ≦ BMI <25): 179 patients (68%), overweight and obese (BMI ≧25): 63 patients (24%). Several factors such as age, sex, cancer stage, body weight change and BMI were recorded and correlated to the postoperative overall survival (OS).
RESULTS: For male patients, those in the low-BMI group had the worst prognosis (P < 0.05) whereas female patients with low BMI did not. Male patients with low BMI had statistically significant poorer prognosis compared to corresponding female patients (P < 0.05). Male patients with more than 5% body weight loss within 1 year after operation when compared to preoperative body weight had poorer prognosis than those with less than 5% body weight loss (P < 0.001). Furthermore, these male patients had statistically significant worse prognosis than the corresponding female patients (P < 0.05). In multivariable analysis, gender, more than 5% of body weight loss compared to preoperative body weight, and pathological stage were independent prognostic factors in NSCLC.
CONCLUSIONS: This study illustrates significant gender differences in the relationship between prognosis and BMI or body weight change in patients with postoperative NSCLC.
© The Author 2017. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Body weight; Gender differences; Non-small cell lung cancer

Mesh:

Year:  2017        PMID: 28444319     DOI: 10.1093/icvts/ivx092

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  5 in total

1.  Complete resection of the primary lesion improves survival of certain patients with stage IV non-small cell lung cancer.

Authors:  Yasuhiro Chikaishi; Shinji Shinohara; Taiji Kuwata; Masaru Takenaka; Soichi Oka; Ayako Hirai; Kazue Yoneda; Kouji Kuroda; Naoko Imanishi; Yoshinobu Ichiki; Fumihiro Tanaka
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

2.  The relationship between body-mass index and overall survival in non-small cell lung cancer by sex, smoking status, and race: A pooled analysis of 20,937 International lung Cancer consortium (ILCCO) patients.

Authors:  Mei Jiang; Aline F Fares; Daniel Shepshelovich; Ping Yang; David Christiani; Jie Zhang; Kouya Shiraishi; Brid M Ryan; Chu Chen; Ann G Schwartz; Adonina Tardon; Sanjay Shete; Matthew B Schabath; M Dawn Teare; Loic Le Marchand; Zuo-Feng Zhang; John K Field; Hermann Brenner; Nancy Diao; Juntao Xie; Takashi Kohno; Curtis C Harris; Angela S Wenzlaff; Guillermo Fernandez-Tardon; Yuanqing Ye; Fiona Taylor; Lynne R Wilkens; Michael Davies; Yi Liu; Matt J Barnett; Gary E Goodman; Hal Morgenstern; Bernd Holleczek; Sera Thomas; M Catherine Brown; Rayjean J Hung; Wei Xu; Geoffrey Liu
Journal:  Lung Cancer       Date:  2020-12-04       Impact factor: 5.705

3.  Low Hematocrit Is a Strong Predictor of Poor Prognosis in Lung Cancer Patients.

Authors:  Xin Zhang; Fengmin Zhang; Wenbo Qiao; Xiansheng Zhang; Zhefeng Zhao; Mingqi Li
Journal:  Biomed Res Int       Date:  2018-10-17       Impact factor: 3.411

4.  Associations of body mass index and hospital-acquired disability with post-discharge mortality in older patients with acute heart failure.

Authors:  Akihiro Sakuyama; Masakazu Saitoh; Kentaro Hori; Yuichi Adachi; Keigo Iwai; Masatoshi Nagayama
Journal:  J Geriatr Cardiol       Date:  2022-03-28       Impact factor: 3.327

5.  Pretreatment neutrophil-to-lymphocyte ratio is a predictive biomarker for EGFR TKI-treated patients with advanced EGFR-mutant Non-small cell lung cancer.

Authors:  Cong Xu; Xiaojun Yao; Ting Li; Jue Wang; Bo An; Jing Wang; Xinbing Sui; Elaine Lai-Han Leung; Qibiao Wu
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.